A novel clinical test developed for RA diagnosis

13 August 2012, USA( Realpharmacyrx.us): As per a recent clinical intervention that was carried out by a team of researchers from the Birmingham’s University of Alabama, the scientists have been successful in producing a novel and unique test that is believed to greatly aid the health care professionals to track down rheumatoid arthritis. The study was conducted under the leadership of Jeffrey Curtis, M.D. of the same university and was sponsored and supported by the National Institutes of Health’s agency of Healthcare Research and Quality. Rheumatoid arthritis is one of the most detrimental diseases that is very complicated for diagnosis and is found to affect almost 3.1 million U.S individuals, with around 75% of them being women. The current employed clinical measures for diagnosis of this delirious health condition that normally occurs in old age is by observing and counting the swollen joints. This method is not only effective but are also very time consuming and complex thereby further aggravating the condition till the time the doctor’s are able to diagnose it. Hence, with the aim of developing a novel clinical method that would not only aid in diagnosis of the disease but also help in tracking down the alterations occurring in the body, the researchers carried out the study and were successful. The test developed by the researchers is known as Vectra DA and analyses the inflammation caused by RA in the patient with the help of 12 biomarkers that are known as cytokines. It helps the medical professionals to diagnose the condition internally and identifying the basic cause of inflammation and that too within less span of time as well as within days of the onset of the disease. The test is also found to greatly aid the Doctor’s is keeping a track of the disease progression as well as the tolerance and response of the patient to the treatment procedure. Realpharmacyrx.us 4th lane, Fontana, California, USA-92337 http://www.realpharmacyrx.us/